Synthesis of substituted anilino-(3-methoxy-4-(4-arylthiosemicarbazidocarbonylmethyleneoxy))benzylidenes: correlation between anticonvulsant activity and monoamine oxidase inhibitory and antihemolytic properties.
D000814:Aniline Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis* / Q000494:pharmacology; D001593:Benzyl Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects; D006461:Hemolysis / Q000187:drug effects*; D066298:In Vitro Techniques; D007737:Kynurenine / Q000494:pharmacology; D008297:Male; D008365:Manometry; D008996:Monoamine Oxidase Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D013055:Spectrophotometry, Infrared; D013882:Thiosemicarbazones / Q000138:chemical synthesis / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000814:Aniline Compounds; D000927:Anticonvulsants; D001593:Benzyl Compounds; D008996:Monoamine Oxidase Inhibitors; D013882:Thiosemicarbazones; D007737:Kynurenine; D010433:Pentylenetetrazole; D014439:Tyramine